(PharmaNewsWire.Com, September 01, 2017 ) “Cardiac Maker Analyzer Market Product Analysis, Business and Marketing Strategy of Cardiac Maker Companies" is a pragmatic solution in the tough financial landscape in which we work. It will build resilience and capacity across both authorities and will help us to retain skilled and experienced staff by providing more opportunities for career development and specialism.
Cardiometabolic products and services provide timely cardiovascular and metabolic information at the point-of-care. Until today, Troponin and CK-MB were the lead cardiac markers. Brain Natriuetic Pepetide (BNP) was recently introduced to differentiate between a Myocardial Infarction and Heart Failure. The routine markers of myocardial infarction – CK-MB, Troponin and Myoglobin and recently BNP are used in the acute care and tests such as Cholesterol are used to evaluate risk. A number of companies are focused on developing new cardiac markers.
All the 12 Cardiac Marker Analyzers in the report have been studied from 6 viewpoints.
Analyzer Specifications and Benefits Net Product Sales Merger, Acquisition & Licensing Agreement Marketing Strategies Methods of Distribution
Alere delivers reliable and actionable health information through rapid diagnostic tests, resulting in better clinical and economic healthcare outcomes globally. Alere’s Cardiology net product sale was more than US$ 600 Million in 2016 and is expected to rule this industry in the future.
Beckman Coulter offers the maximum number of cardiac marker tests on its cardiology platform while Abbott Laboratories (i-Stat) and Siemens Healthineers (Stratus® CS Analyzer) also perform several cardiac marker tests on their cardio-metabolism platform and establishes them as the leader in this market.
Cardiac Markers Analyzers usually measure the levels of enzymes and proteins released from heart muscle when it is damaged. Physicians use cardiac markers in two ways – to diagnose a cardiac event in a hospital emergency room or within the hospital or to evaluate a risk of a cardiovascular event occurring.
Cardiac Maker Analyzer – Product Analysis, Business & Marketing Strategy of Cardiac Maker Companies is the 2nd report published by Renub Research. This 105 page report contains 14 Figures and 12 Tables provides a comprehensive analysis of the cardiac markers analyzer segments, including their comparative tests analysis, competitive product analysis, product features, merger, acquisitions, analyzer sales figures and Business and Market Strategies of Companies.
TOC:
Executive Summary Cardiac Marker Companies – Comparative Tests Analysis Cardiac Marker Analyzer – Competitive Product Analysis Alere Response Biomedical Abbott Point of Care Roche Siemens Healthineers Beckman Coulter Boditech Lifesign LSI Medience Corporation Trinity Biotech CardioGenics Holdings Inc. Mergers, Acquisitions and Licensing Agreements Emerging Markers Response Biomedical – Business & Marketing Strategy Roche – Business & Marketing Strategy Siemens Healthineers – Business and Marketing Strategy Boditech Med Inc – Business and Marketing Strategy
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
